Bristol-Myers Squibb Co Investor Event at European Society of Medical Oncology Transcript
Good day, and welcome to the BMS ESMO IR event. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Tim Power, Vice President, Investor Relations. Please go ahead, sir.
Thanks, Justin, and good afternoon, everybody. Thanks for joining us today for our 2020 ESMO investor meeting. I just want to make sure that you're aware that we've posted slides to bms.com that you can use to follow along with today's discussion. And obviously, we'll have time for Q&A afterwards.
But joining me today for the presentation are Samit Hirawat, our Chief Medical Officer and Head of Global Drug Development; as well as Chris Boerner, our Chief Commercialization Officer. Giovanni Caforio, our Board Chair and Chief Executive Officer, as well as some other members of our oncology team are also here for the Q&A.
But before we get going, I'll read our forward-looking statements. During today's call, we'll make statements about the company's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
